Clinical Trial

Influence of Authorized Smokeless Tobacco Product Modified Risk Claims II: Laboratory Assessment of Sensory and Subjective Effects

Recruiting
View on ClinicalTrials.gov →
Summary
This study seeks to measure the effects of smokeless tobacco product risk messages on sensory experiences and future intentions to use.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2027-03-01 -> 2027-05-01 2026-05-23
minor Completion pushed: 2027-03-01 -> 2027-05-01 2026-05-23
Trial Details
NCT Number NCT07107139
Lead Sponsor Roswell Park Cancer Institute
Collaborators: National Cancer Institute (NCI)
Conditions Smokeless Tobacco
Enrollment 50 participants
Start Date 2026-05-11
Primary Completion 2027-05-01 (estimated)
Study Completion 2027-05-01 (estimated)
Updated on ClinicalTrials.gov 2026-05-22